Workplace Solutions: Medication-Assisted Treatment for Opioid Use Disorder

Details

• Journal Article:
  National Institute for Occupational Safety and Health
• Personal Author:
  Howard, John J. ; Cimineri, Lauren ; Evans, Tamekia ; Chosewood, L. Casey ; Afanuh, Susan E.
• Description:
  The opioid overdose epidemic continues to claim lives across the country with a record 47,600 overdose deaths in 2017. (This number represents 67.8% of the 70,237 overdose deaths from all drugs) [CDC 2018a]. More Americans now die every year from drug overdoses than in motor vehicle crashes [CDC 2016]. The crisis is taking an especially devastating toll on certain parts of the U.S. workforce. High rates of opioid overdose deaths have occurred in industries with high injury rates and physically demanding working conditions such as construction, mining, or fishing [Massachusetts Department of Public Health 2018; CDC 2018b]. Certain job factors such as high job demands, job insecurity, and lack of control over tasks have also been linked to opioid use [Kowalski-McGraw et al. 2017]. Medication-assisted treatment (MAT) (also known as medicationbased treatment*) has been shown to be effective for many people with opioid use disorder [SAMHSA 2015b; National Academies of Sciences, Engineering, and Medicine 2019]. In addition to providing general information about MAT, this document provides information for employers wishing to assist or support workers with opioid use disorder. [Description provided by NIOSH]
• Subjects:
  Construction Industry Hunting Mining Narcotics Occupational Health Personal Protective Equipment Protective Clothing Safety Stress, Psychological
• Keywords:
  Narcotics; Personal protective equipment; PPE; Protective clothing; Protective measures; Gloves; Construction industry; Mining; Fishing; Fishing industry; Injuries; Traumatic injuries; Job stress
• Source:
  Washington, DC : U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2019-133, 2019 May; :1-7
• Series:
  NIOSH Numbered Publications
• Subseries:
  Workplace Solutions
• DOI:
  https://doi.org/10.26616/NIOSHPUB2019133
• Publisher:
  National Institute for Occupational Safety and Health
• Document Type:
  Text
• Genre:
  Periodical
• Place as Subject:
  District of Columbia ; Georgia ; Ohio ; OSHA Region 3 ; OSHA Region 4 ; OSHA Region 5
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  OD - Office of the Director ; WTCHP - World Trade Center Health Program ; EID - Education and Information Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  7 pdf pages
• NIOSHTIC Number:
  nn:20055929
• NTIS Accession Number:
  PB2019-101133
• CAS Registry Number:
  (±)-Methadone (CAS RN 76-99-3) ; Buprenorphine (CAS RN 52485-79-7) ; Naltrexone (CAS RN 16590-41-3)
• Federal Fiscal Year:
  2019
• NORA Priority Area:
  Construction ; Manufacturing
• Peer Reviewed:
  False
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:1e5ee7f9d7f972858d05f5d4adc8e6a2a52ecd6112199658fe439617728f5540477dffeb2b939b92eff0b598a64024fbf517fb79588130f73b538db6535bb2d3
• Download URL:
  https://stacks.cdc.gov/view/cdc/78827/cdc_78827_DS1.pdf
• File Type:
  [PDF - 743.77 KB ]